Applied Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

• Applied Therapeutics Inc APLT.OQ reported a quarterly adjusted loss of 15 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -67 cents. The mean expectation of four analysts for the quarter was for a loss of 19 cents per share. Wall Street expected results to range from -22 cents to -16 cents per share.

• Reported revenue was zero​; analysts expected $4.58 million.

• Applied Therapeutics Inc's reported EPS for the quarter was a loss of 15 cents​.

• The company reported a quarterly loss of $21.83 million.

• Applied Therapeutics Inc shares had fallen by 10.0% this quarter and lost 48.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 67.7% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

• Wall Street's median 12-month price target for Applied Therapeutics Inc is $2.50

This summary was machine generated from LSEG data May 14 at 08:41 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)